EurekaMag.com logo
+ Translate

Evidence of breast cancer mortality reduction: aggressive screening in women under age 50


, : Evidence of breast cancer mortality reduction: aggressive screening in women under age 50. Ajr. American Journal of Roentgenology 138(5): 911-916

Five year follow-up data for breast cancer screening of 10,531 self-selected women are presented. The data are compared with the Health Insurance Plan of New York population and it appears that the magnitude of the mortality reduction in these two populations is similar. However, contrary to the New York findings, the data demonstrate that the benefit to screening this population was maximal in women under age 50. No breast cancer deaths have been recorded in 5 years of follow-up in this younger population (6,030 individuals). Interpretation of the data is that aggressive screening for breast cancer can favorably alter breast cancer mortality, particularly in younger women.

(PDF same-day service: $19.90)

Accession: 005411274

PMID: 6979179

DOI: 10.2214/ajr.138.5.911

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Kopans, D.B.; Halpern, E.; Hulka, C.A., 1994: Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74(4): 1196-1203

Kopans, Daniel B., 1994: Screening for breast cancer and mortality reduction among women 40-49 years of age. The recent withdrawal of screening support for women ages 40-49 years is not scientifically supported. The subgroup analyses that have been used severely compromise the statistical power of the trials. None of the trials has the statistical power...

Van Dijck, J.A.; Verbeek, A.L.; Beex, L.V.; Hendriks, J.H.; Holland, R.; Mravunac, M.; Straatman, H.; Werre, J.M., 1996: Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality. We evaluated whether regular mammographic screening of women aged 65 years or older affected breast cancer mortality. In Nijmegen, a population-based screening program for breast cancer was started in 1975, with biennial mammography for women aged...

D.K.ning, H.J.; Fracheboud, J.; Boer, R.; Verbeek, A.L.; Collette, H.J.; Hendriks, J.H.; van Ineveld, B.M.; de Bruyn, A.E.; van der Maas, P.J., 1995: Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). The nation-wide 2-yearly breast-cancer screening programme in The Netherlands, for women aged 50-69, started around 1988, and was predicted to result eventually in a 16% reduction in breast-cancer mortality in the total female population. We prese...

Tabár, L.; Fagerberg, C.J.; Gad, A.; Baldetorp, L.; Holmberg, L.H.; Gröntoft, O.; Ljungquist, U.; Lundström, B.; Månson, J.C.; Eklund, G., 1985: Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. A randomised controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breast cancer was started in Sweden in 1977. 162 981 women aged 40 years or more and living in the counties of Kopp...

Tabar L.; Gad A.; Holmberg L.H.; Ljungquist U.; Eklund G.; Fagerberg C.J.G.; Baldetorp L.; Grontoft O.; Lundstrom B.; E.A., 1985: Reduction in mortality from breast cancer after mass screening with mammography randomized trial from the breast cancer screening working group of the swedish national board of health and welfare. A randomized controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breast cancer was started in Sweden in 1977. Women (162,981) aged 40 yr or more and living in the counties of Koppa...

Latosinsky, S.; George, R.; Cody, H.S.; Baxter, N.N.; Brasel, K.J.; Brown, C.J.; Chaudhury, P.K.; Divino, C.M.; Dixon, E.; Fitzgerald, G.William.N.; Hameed, S.Morad.; Henteleff, H.J.; Hughes, T.G.; Kao, L.S.; Kirkpatrick, A.W.; Latosinsky, S.; Mastracci, T.M.; McLeod, R.S.; Morris, A.M.; Pawlik, T.M.; Temple, L.K.; McKenzie, M., 2013: Does screening for breast cancer with five screening modalities in average-risk women reduce mortality from breast cancer?. Journal of the American College of Surgeons 216(6): 1214-1217

Nicholson S.; Armstrong J.; Davies J.; Coghlan B.; Webb A.J.; Farndon J.R., 1991: The biology of screen detected breast cancer can breast screening be expected to reduce mortality evidence from the first year of screening in bristol. British Journal of Cancer 64(SUPPL 15): 9

Hofvind, S.; Wang, H.; Thoresen, S., 2004: Do the results of the process indicators in the Norwegian Breast Cancer Screening Program predict future mortality reduction from breast cancer?. Continuous emphases of quality control are required to achieve reduction in mortality from breast cancer as a consequence of breast cancer screening. Results of the process indicators in the first 6 years in 4 counties in the Norwegian Breast Canc...

National-Evaluating-Team-For-Breast-Cancer-Screening, 1995: Nation-wide breast cancer screening in the Netherlands: Support for breast-cancer mortality reduction. The nation-wide 2-yearly breast-cancer screening programme in The Netherlands, for women aged 50-69, started around 1988, and was predicted to result eventually in a 16% reduction in breast-cancer mortality in the total female population. We prese...